FitnessSyncer unifies your data in one convenient place so you can make informed decisions toward better results. Analyze your data in our customizable dashboard, stream, exportable calendar, daily analyzer, and more! You're already doing the hard work
23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe's data to study Parkinson's. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it's been about selling your data all along.